Baxter International Inc. (BAX) Stock Could Soon Reward Patient Investors

Baxter International Inc. (NYSE: BAX) is 2.30% higher on its value in year-to-date trading and has touched a low of $31.01 and a high of $50.21 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BAX stock was last observed hovering at around $40.46 in the last trading session, with the day’s loss setting it -0.91%.

Currently trading at $39.55, the stock is 1.31% and 3.01% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.75 million and changing -2.25% at the moment leaves the stock -1.46% off its SMA200. BAX registered -13.42% loss for a year compared to 6-month loss of -8.00%. The firm has a 50-day simple moving average (SMA 50) of $2.11 and a 200-day simple moving average (SMA200) of $92.11.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

The stock witnessed a -1.84% gain in the last 1 month and extending the period to 3 months gives it a 16.15%, and is 1.46% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.96% over the week and 2.40% over the month.

Baxter International Inc. (BAX) has around Nov 30 2023 employees, a market worth around $20.06B and $14.95B in sales. Fwd P/E is 12.31. Profit margin for the company is -1.51%. Distance from 52-week low is 27.54% and -21.23% from its 52-week high. The company has generated returns on investments over the last 12 months (-1.13%).

Baxter International Inc. quarterly earnings per share for the current quarter are estimated at $0.63 with sales reaching $3.62B over the same period.The EPS is expected to grow by 11.29% this year, but quarterly earnings will post 2.30% year-over-year. Quarterly sales are estimated to grow 0.40% in year-over-year returns.

Baxter International Inc. (BAX) Top Institutional Holders

1,231 institutions hold shares in Baxter International Inc. (BAX), with institutional investors hold 92.93% of the company’s shares. The shares outstanding are 507.63M, and float is at 503.51M with Short Float at 1.48%. Institutions hold 92.69% of the Float.

The top institutional shareholder in the company is Blackrock Inc. with over 65.17 million shares valued at $2.97 billion. The investor’s holdings represent 12.87% of the BAX Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 60.64 million shares valued at $2.76 billion to account for 11.98% of the shares outstanding. The other top investors are State Street Corporation which holds 21.51 million shares representing 4.25% and valued at over $979.97 million, while Price (T.Rowe) Associates Inc holds 3.01% of the shares totaling 15.25 million with a market value of $694.97 million.

Baxter International Inc. (BAX) Insider Activity

A total of 3 insider transactions have happened at Baxter International Inc. (BAX) in the last six months, with sales accounting for 1 and purchases happening 2 times. The most recent transaction is an insider sale by STROUCKEN ALBERT P L ,the company’sDirector. SEC filings show that STROUCKEN ALBERT P L sold 3,930 shares of the company’s common stock on Mar 20 at a price of $37.52 per share for a total of $0.15 million. Following the sale, the insider now owns 36835.0 shares.

Baxter International Inc. disclosed in a document filed with the SEC on Feb 21 that Kunzler Jacqueline (SVP, Chief Quality Officer) sold a total of 3,813 shares of the company’s common stock. The trade occurred on Feb 21 and was made at $40.50 per share for $0.15 million. Following the transaction, the insider now directly holds 16725.0 shares of the BAX stock.

Baxter International Inc. (BAX): Who are the competitors?

The company’s main competitors (and peers) include Medtronic PLC (MDT) that is trading 0.71% up over the past 12 months. Stryker Corp. (SYK) that is 28.08% higher over the same period.